Current and future immunotherapeutic approaches in pancreatic cancer treatment

The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma